Note: If you use other eye drops in addition to Restasis, you can probably still use those drops while you’re using Restasis. But make sure to check with your doctor about which eye drops are safe to ...

The US Food and Drug Administration (FDA) has approved Amneal Pharmaceuticals’ cyclosporine ophthalmic emulsion 0.05%, which ...

Patients treated with a single interventional eyelid procedure enabled by TearCare® technology after receiving Restasis® for the first six months of the trial realized clinically meaningful ...

Allergan announced it has received FDA approval for Restasis Multidose, a preservative-free, multidose bottle offering the same formulation as Restasis for patients with chronic dry eye who need to ...

Allergan is spiking up $2.31, or 4.4 percent, to $55.05 after the company said the U.S. Food and Drug Administration had approved Restasis use in patients suffering from chronic dry eye disease. The ...

Yes, people with Medicare Part D who use Restasis may be eligible for a patient assistance program called myAbbVie Assist. This article discusses whether Medicare covers Restasis, Medicare ...

Sight Sciences Inc SGHT released the six-month SAHARA randomized controlled trial comparing interventional eyelid procedures enabled by TearCare Technology to Restasis for dry eye disease. TearCare is ...

Dear Dr. Roach: My wife, who’s 72, has had very dry eyes for a long time, so she uses Restasis (cyclosporine emulsion 0.05%) eye drops. Her co-pay (after meeting the deductible) last year was around ...

The Food and Drug Administration (FDA) has approved Restasis for treating chronic dry eye in adults and children ages 16 years and older. It’s available in single-use vials and a multiuse bottle.

MENLO PARK, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing ...